Global Orthobiologics Market to Reach $5,519.9 Million by 2019

Global Orthobiologics Market to Reach $5,519.9 Million by 2019

Orthobiologics Market (Allografts, Viscosupplements, DBM, BMP, Stem Cell and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

In its latest report, Transparency Market Research, a U.S.-based market intelligence firm states that the global orthobiologics market is estimated to be worth $ 5,519.9 million by the end of 2019. The report, titled ‘Orthobiologics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,’also states that the market for orthobiologics across the world was worth $3,745.6 million in 2012 and will grow at a compound annual growth rate (CAGR) of 5.9% in the forecast period.

Browse the full Orthobiologics Market Report at http://www.transparencymarketresearch.com/orthobiologics-market.html

Nearly half of the population aged 50 years and above is afflicted by bone and joint disorders, and this number is expected to almost double by the year 2020. This has and will continue to increase the demand for orthobiologics. Other factors which have fueled the growth of the orthobiologics market are technological advances, declining usage of allografts and autografts in orthopedic procedures, change in lifestyle, increase in obesity cases, and rise in sports activities and sports injuries.

However, the strict regulatory requirements and lack of reimbursement are expected to restrain market growth.

According to the report, the market for orthobiologics can be segmented on the basis of products, applications, and geography.
Product: The various product types of orthobiologics include machined bones, allografts, bone morphogenetic proteins (BMPS), demineralized bone matrix (DBM), stem cell therapy, synthetic bone substitutes, and viscosupplementation.
Applications: The numerous applications of orthobiologics are trauma, spinal fusion, and reconstructive surgery.

Geography: The orthobiologics...